At the Medicine department office
Appointment on Visitation important
Topic: CLINICAL PATTERNS OF LUNG CANCER IN LAGOS STATE UNIVERSITY TEACHING HOSPITAL
Lung cancer is a growing concern worldwide and a leading cause of cancer-related deaths.
According to Global Cancer statistics 2020, Lung cancer accounts for 11.4% of all new cancer cases and 18% of cancer deaths. In the African subcontinent, there is limited information on the prevalence of lung cancer. The true incidence of lung cancer in Nigeria is not known however hospital-based studies have reported an increasing incidence. The Global Cancer Observatory estimates that Lung cancer will account for 1.32% of all new cancer cases and 2.03% of cancer mortality in Nigeria.
Currently, no study has documented the clinical profile of lung cancer patients seen in LASUTH.
There is also no harmonized registry of lung cancer patients in various clinics (Oncology, Cardiothoracic, Respiratory medicine Radiology, and Pathology).
This study aims to describe the clinical patterns of lung cancer in patients attending Lagos State.
The findings from this study will assist in identifying the common presentation and clinicopathological profile of lung cancer patients in LASUTH and facilitate diagnosis and case management in the hospital. It will also elucidate the need for the hospital management to come up with policies that will aid the creation of a lung cancer registry.
The study will bring to the fore the need for multidisciplinary cancer management in the hospital.
|FWACP (INTERNAL MEDICINE/PULMONOLOGY)
|WEST AFRICAN COLLEGE OF PHYSICIAN
POST COVID-19 LUNG DISEASE: LAGOS EXPERIENCE
COVID-19 can cause damage to organs throughout the body. This increases the risk of long-term health problems that individuals may continue to face months after the initial infection. The lungs are the first organs affected by COVID-19 infection, therefore Post-COVID-19 lung disease is one of the most common consequences of COVID-19 infection. Older adults and people with underlying medical conditions are more likely to have lingering COVID-19 symptoms. COVID-19 infection is still not completely understood and should be included in further studies.
The aim of this study is evaluate the profile of lung manifestations of patients previously treated for COVID- 19 infection.
A cross-sectional survey with a semi-structured questionnaire using a random sampling technique will be conducted during this study. Data collected were analyzed using descriptive statistics.
will identify various lung abnormalities following infection with
sarscov2. It will also evaluate the risk factors for lung sequelae as
well as the severity of lung abnormalities
This study will describe the prevalence, nature and also determines predictors of sequelae in a cohort of COVID-19 survivors in Lagos Nigeria.
OJO OLUWAFEMI is a Lecturer I at the Department of Medicine
OJO has a FWACP in INTERNAL MEDICINE/PULMONOLOGY from WEST AFRICAN COLLEGE OF PHYSICIAN